Potentiometric determination of captopril in pharmaceutical formulations

Ecletica Quimica

Volumn 28, Issue 1, 2003, Pages 39-44

  Ribeiro, P R D S ^a   Santini, A O ^a   Pezza, H R ^a   Pezza, L ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Captopril; Pharmaceutical formulations; Potentiometric determination

Indexed keywords

CAPTOPRIL; CELLULOSE; CROSCARMELLOSE SODIUM; LACTOSE; MAGNESIUM STEARATE; STARCH;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; INTERMETHOD COMPARISON; PH ELECTRODE; POTENTIOMETRIC TITRATION; POTENTIOMETRY; TABLET; TITRIMETRY;

EID: 3242698142     PISSN: 01004670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-46702003000100005     Document Type: Article

References (28)

1. ASHOUR, F. M.; SALAMA, F. M.; AZIZA, M. A. E. A colorimetric method for the determination of captopril. J. Drugs Res., v. 19, n. 1-2, p. 323-326, 1990.
2. ASKAL, H. F. New spectrophotometric methods for determination of captopril bulk drug and tablets. Talanta,
3. BALD, E.; SYPNIEWSKI, S. Determination of thiol drugs in pharmaceutical formulations as their 5-pyridinium derivatives by high-performance liquid chromatography with ultraviolet detection. Fresenius J. Anal. Chem., v. 358, n. 4, p. 554-555, 1997.
4. CAVRINI, V.; GATTI, R.; DIPRETA, A. M.; RAGGI, M. A. Determination of thiol drugs in pharmaceutical formulations using ethacrynic-acid as a precolumn ultraviolet derivatizaon reagent. Chromatographia, v. 23, n. 9, p. 680-683, 1987.
5. CAVRINI, V.; GATTI, R.; ANDRISANO, V.; GATTI, R. 1,1′- [ethenylidenebis (sulfonyl)] bis-benzene: A useful pre-cromatographic derivatization reagent for HPLC analyses of thiol drugs. Chromatographia, v. 42, n. 9-10, p. 515-520, 1996.
6. DAVIS, R.; RIBNER, H.; KEUNG, E.; SONNENBLICK, E.; LE-JEMTEL, T. Treatment of chronic congestive heart-failure with captopril, and oral inhibitor of angiotensin converting enzyme. New England J. Med., v. 301, n. 3, p. 1 17-121, 1979.
7. EL-ASHRY, S. M.; IBRAHIM, F. A. Colorimetric determination of captopril in dosage forms. Anal. Lett., v. 25, n. 9, p. 1657-1672, 1992.
8. EL-BRASHY, A. M. Titrimetric determination of captopril in dosage forms. Acta Pharm. Hung., v. 65, n. 3, p. 91-93, 1995.
9. FAVARO, G.; FIORANI, M. Determination of pharmaceutical thiols by chromatography with electrochemical detection: use of an electrode with conductive carbon cement matrix, chemically modified with cobalt phthalocyanine. Anal. Chim. Acta, v. 332, n. 2-3, p. 249-255, 1996.
10. FRAGA, J. H. G.; ABIZANDA, A. I. J.; MORENO, F.J.; LEON, J. J. A. Application of principal component regression to the determination of captopril by differential pulse polarography with no prior removal of dissolved oxygen. Talanta, v. 46, n. 1, p. 75-82, 1998.
11. FIORY, K. Analytical profiles of drugs substances. New York: Academic Press, 1982, v. 11. 81 p.
12. GUERRERO, R. S.; VIVES, S. S.; CALATAYUD, J. M. Fluorometric determination of captopril by flow injection analysis. Microchem. J., v. 43, p. 176-180, 1991.
13. HILLAERT, S.; VAN DEN BOSSCHE, W. Determination of captopril and its degradation products by capillary electrophoresis. J. Pharm. Biomed. Anal., v. 21, n. 1, p. 65-73, 1999.
14. JOVANIVIC, T.; STANOVIC, B.; KORICANAC, Z. Spectrophotometric investigation on complex-formation of captopril with palladium (II) and its analytical application. J. Pharm. Biomed. Anal., v. 13, n. 3, p. 213-217, 1995.
15. KOCH-WESTER, J. Angiotensin converting-enzyme inhibitor in refractory hypertension. New England J. Med., v. 299, p. 363-364, 1978.
16. LEITE, F. Validação em análise química. 3a ed. Campinas: Editora Átomo, 1998.p. 68.
17. MOHAMED, M. E.; ABOUL - ENEIN, H. Y.; GADKARIEM, E. A. Potentiometric and visual titrimetric methods for analysis of captopril and its pharmaceutical forms. Anal. Lett., v. 16, n. B1, p. 45-55, 1983.
18. MOHAMED, M. E.; ABOUL - ENEIN, H. Y. Amperometric and conductimetric method for simultaneous determination of captopril and bendroflumethiazide. Anal. Lett., v. 18, n. B20, p. 2591-2603, 1985.
19. NIKOLIC, K.; VALASEVIC, K. S. Conductometric determination of captopril. Phamazie, v. 44, n. 2, p. 155-156, 1989.
20. NIKOLIC, K.; VALASEVIC, K. S. Coulometric determination of captopril. Acta Pol. Pharm., v. 48, n. 1-2, p. 5-7, 1991.
21. PALOMEQUE, M. E.; BAND, B. S. F. Flow injection biamperometric determination of captopril. J. Pharm. Biomed. Anal., v. 30, n. 3, p. 547-552, 2002.
22. SANGHAVI, N. M.; SAMARTH, M. M.; MATHARU, R.; SINGH, P. S. Colorimetric estimation of captopril and its formulations. Indian Drugs, v. 28, n. 4, p. 189-191, 1991.
23. SARNA, K.; FIJALEK, Z. Voltammetric and electrochemical quartz crystal microbalance study of antithyroid drugs. Chem. Anal., v. 42, n. 3, p. 425-433, 1997.
24. SASTRY, C. S. P.; SAILAJA, A.; RAO, T. T. Determination of captopril by two simple spectrophotometric methods using oxidative coupling reaction. Pharmazie, v. 46, n. 6, p. 465-457, 1991.
25. SKOOG, D. A.; WEST, D. M.; HOLLER, F. J. Fundamentals of analytical chemistry. 6th ed. Chicago: Saunders College Publishing, 1996. 849 p.
26. STEFAN R. I.; VAN STADEN, J. F.; ABOUL - ENEIN, H. Y. A new construction for a potentiometric, enantioselective membrane electrode - its utilization to the S-captopril assay. Talanta, v. 48, n. 5, p. 1139-1143, 1999.
27. UNITED STATES PHARMACOPEIAL CONVENTION. The United States pharmacopeia: the national formulary: captopril. 24th ed. Rockville, 2000. p. 296-298.
28. ZHANG, Z. D.; BAEJENS, W. R. G.; ZHANG, X. R.; VAN DER WAKEN, T. Chemiluminescense flow injection analysis of captopril applying a sensitized rhodamine 6G method. J. Pharm. Biomed. Anal., v. 14, n. 8-10, p. 939-945, 1996.